NYSE: EMR · Industrial Machinery

Emerson Electric (EMR) fair value: undervalued or overvalued?

As of 14 Nov 2026, Faircurve's model values Emerson Electric (EMR) at $160.41 a share. The stock last closed at $160.69, which puts the model's fair value 0.2% below the price. On the model's bands that reads as Fairly valued.

Revalued . Price is the close of 16 Nov 2026. Emerson Electric Co.

The report adds the live price, the chart against the range the options market prices, the next earnings date and the analysts' consensus. No account needed.

Model fair value$160.41midpoint of 2,000 simulations
Last close$160.69NYSE: EMR
Gap to fair value-0.2%fair value against price
Model verdictFairly valuedevidence grade: High

This week, in three parts

What happenedThe run of 14 Nov 2026 moved the fair value from $164.90 to $160.41 (-2.7%). Analysts cut their next-twelve-month EBITDA estimates: most of the move.

What the model makes of itThe price of $160.69 is level with it: Fairly valued, on a high evidence grade.

What's nextNext report on 2 Feb 2027. Options prices imply a move of about 9% either way over the next month. The next weekly run is on Saturday 21 Nov 2026.

What price range does the model give EMR?

The calibrated range for EMR over 63 trading days is $144.33 to $179.87. It sits around the last close, and its width comes from the volatility that EMR's own options imply (33% a year), calibrated weekly against realised prices (n = 8,038 past valuations, refreshed 14 Nov 2026). Ranges built this way held the price 60% of the time at this horizon. The fair value is the model's opinion and rides beside the range. It is not the centre of it.

The model's own simulated range, from the 20th to the 80th percentile of its runs, is $130.43 to $194.15. In 44% of the simulations the fair value came out above the price the model ran on.

$101.33$246.77
Spread of the 2,000 simulated fair values. Solid line: the midpoint, $160.41. Dashed line: the last close, $160.69.

Faircurve Insights · 14 Nov 2026

Emerson Electric Co. is an international technology and engineering firm serving industrial, commercial and residential clients across the Americas, Asia, the Middle East, Africa and Europe.

Faircurve's model gives Emerson Electric a fair value of $160.41 a share on 14 Nov 2026, the midpoint of 2,000 simulations. The previous run, on 7 Nov 2026, gave $164.90, so the fair value moved -2.7%. In the model's own words, analysts cut their next-twelve-month EBITDA estimates: most of the move. The calibrated range over 63 trading days is $150.68 to $184.64. It is built from the volatility the stock's own options imply and calibrated weekly against realised prices, using 8,038 past valuations refreshed on 14 Nov 2026. Ranges built this way held the price 60% of the time at this horizon. The model grades the evidence High. That grade reflects input completeness, the number and agreement of comparable companies, and the width of outcomes. It does not say whether the fair value is right.

The model gives Emerson an overall quality score of 42 out of 100, measured against comparable companies. Earnings quality is the highest factor at 93, with FCF / net income of 1.32x against a peer median of 0.88x. Profitability is the lowest at 5, with ROIC of 9.5% against a peer median of 24.9%. Balance sheet scores 33, with net debt / EBITDA of 1.94x against a peer median of 1.60x. The model compares Emerson with Trane Technologies plc, Illinois Tool Works Inc., Parker-Hannifin Corporation, Cummins Inc., PACCAR Inc, Rockwell Automation, Inc. and Carrier Global Corporation.

Written from the figures on this page for the 14 Nov 2026 valuation and checked by rule before publishing: every number is one printed here, no forecast, no instruction. The price, the gap and the verdict are the page's own and change daily. Not a recommendation.

The Global Pulse

Faircurve's note after each US session, in your inbox. No account needed.

When does EMR report earnings, and how has the stock reacted?

Emerson Electric's next earnings report is scheduled for 2 Feb 2027. Companies can move their dates.

Options prices on 16 Nov 2026 imply a move of about 4.9% in either direction through the nearest expiry, about 10 days out. That is the size the market is pricing, not a direction. EMR's 30 day implied volatility works out to about 9.4% over one month.

Around its last 8 reports: what the options market priced, and what followed

Each move runs from the last close before the report to the first close after it, so it covers companies that report before the open and after the close. The median size across EMR's last 8 reports, ignoring direction, was 4.8%.

0%5%10%6.3%0.2%5 Feb '256.3%4.8%7 May '256.3%5.5%6 Aug '257.0%4.5%5 Nov '255.6%5.8%3 Feb '267.5%9.2%5 May '265.2%4.9%4 Aug '266.0%2.3%4 Nov '26priced before the reportthe move that followed
What the options market priced for each report, against the size of the move that followed. Priced: the move implied by options expiring after the report, on the last quote before it. Followed: the close before the report to the close after. Sizes only, no direction.

What the options market has priced for a month's move in EMR

0%5%10%15%4 Nov '26 report4 Aug '26 report5 May '26 report3 Feb '26 report9% at 16 Nov '2614 Nov '2516 Nov '26
What the options market priced for a month's move (30-day implied volatility, scaled to one month). It read 9% on 14 Nov 2025, reached 12% on 24 Apr 2026 and reads 9% on 16 Nov 2026. The marks are report dates.

How does EMR score on business quality?

Emerson Electric's overall quality score is 42 out of 100. Each factor below is a score against comparable companies, not a percentile of the metric beside it.

FactorScore (0 to 100)Headline measurePeer median
ProfitabilityReturn on invested capital against the peer group, with a bonus for an improving trend.59.5%ROIC24.9%
Earnings qualityHow much of reported profit is cash: free cash flow to net income, and the accrual ratio (the share of earnings that is not cash).931.32xFCF / net income0.88x
Growth qualityTrailing revenue growth, forward growth from consensus, and the direction of analysts' rating changes.435.4%Revenue growth, trailing7.8%
Capital disciplineReinvestment efficiency (capital spending per unit of revenue) and net buybacks.501.1%Net buybacks / market value2.5%
Balance sheetNet debt to EBITDA and interest coverage.331.94xNet debt / EBITDA1.60x
StabilityDownside volatility of the EBITDA margin over the last five years.501.5 ptsEBITDA margin downside volatility, 5y1.4 pts

How does EMR compare with similar companies?

The companies in industrial machinery closest to Emerson Electric in market value, each on the same model and the same date.

CompanyLast closeModel fair valueGapModel verdict
TT Trane Technologies plc$407.99$414.83+1.7%Fairly valued
ITW Illinois Tool Works Inc.$284.64$287.27+0.9%Fairly valued
HON Honeywell International Inc.$217.95$211.15-3.1%Data under review
PH Parker-Hannifin Corporation$934.80$870.55-6.9%Fairly valued
CMI Cummins Inc.$432.72$526.44+21.7%Undervalued
PCAR PACCAR Inc$105.53$107.20+1.6%Fairly valued
ROK Rockwell Automation, Inc.$384.90$386.76+0.5%Fairly valued
CARR Carrier Global Corporation$51.67$54.94+6.3%Fairly valued

What the comparable companies' multiples alone would give for EMR, the peer-implied price, is $150.35 a share on this run. The fair value weighs that against the company's own multiple.

All industrial machinery stocks ranked by gap to fair value

Emerson Electric at a glance

Emerson Electric Co. is an international technology and engineering firm that delivers diverse solutions to industrial, commercial, and residential clients across the Americas, Asia, the Middle East, Africa, and Europe.

Market value
$91.3B
Sector
Industrials
Industry
Industrial Machinery
Revenue expected, next twelve months
$20.1B
Consensus revenue growth, next fiscal year
+5.3%
Analysts with estimates
17
Beta to the US market
1.45
First valued by Faircurve
1 May 2026

At the close of 16 Nov 2026, 56.8% of the 1,085 graded US stocks the model covers traded below the model's fair value. EMR was not among them.

How the fair value is worked out: the model prices Emerson Electric on the value of the whole business, debt included, against the operating profit analysts expect next year (forward EV/EBITDA), runs 2,000 simulations across its inputs and takes the midpoint. The full method is documented here.

What changed in the latest valuation?

On 7 Nov 2026 the model's fair value for EMR was $164.90. As of 14 Nov 2026 it is $160.41, a change of -2.7%. Analysts cut their next-twelve-month EBITDA estimates: most of the move. The model revalues every stock it covers each week, and again after an earnings report.

Questions about Emerson Electric's valuation

Is Emerson Electric stock undervalued or overvalued?

On Faircurve's model, EMR reads as Fairly valued as of 14 Nov 2026. The model's fair value is $160.41 a share against a last close of $160.69, a gap of -0.2%.

What is EMR's fair value?

$160.41 a share as of 14 Nov 2026, the midpoint of 2,000 simulations. The model's own 20th to 80th percentile range is $130.43 to $194.15.

What price range does the model give EMR?

$144.33 to $179.87 over 63 trading days. Ranges built this way held the price 60% of the time across 8,038 past valuations, refreshed 14 Nov 2026.

When does Emerson Electric report earnings next?

The next report is scheduled for 2 Feb 2027. Companies can move their dates.

How much has EMR moved on past earnings reports?

Across its last 8 reports the median two session move was 4.8%, ignoring direction. The largest was +9.2% around the report of 5 May 2026.

How confident is the model in this valuation?

The model's evidence grade for EMR is high. The grade looks at how complete the inputs are, how many comparable companies there are and how closely they agree, and how wide the range of outcomes is. It is not a probability that the fair value is right, or that the price reaches it.

The model's own ideas on EMR

The model holds no idea open on EMR today. Signed-in readers see the rule each idea runs on, the floor and the exit level the model set and its time limit, and the model's closed ideas on EMR with their outcomes. A free account is enough.

Keep reading